N-(1-(butylamino)-3-((4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-((2R,3R,4S,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-16-ethyl-4-hydroxy-15-(((2S,3S,4S,5S,6S)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yloxy)methyl)-5,9,13-trimethyl-2,10-dioxooxacyclohexadeca-11,13-dien-7-yl)-1-oxopropan-2-yl)-N-isopropylbenzamide

ID: ALA4549457

Chembl Id: CHEMBL4549457

PubChem CID: 155550575

Max Phase: Preclinical

Molecular Formula: C54H87N3O15

Molecular Weight: 1018.30

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCNC(=O)C(C[C@H]1C[C@@H](C)C(=O)/C=C/C(C)=C/[C@H](CO[C@H]2O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]2OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]1O)N(C(=O)c1ccccc1)C(C)C

Standard InChI:  InChI=1S/C54H87N3O15/c1-14-16-24-55-51(64)39(57(30(3)4)52(65)36-20-18-17-19-21-36)27-37-26-32(6)40(58)23-22-31(5)25-38(29-68-54-50(67-13)49(66-12)46(62)35(9)70-54)42(15-2)71-43(60)28-41(59)33(7)48(37)72-53-47(63)44(56(10)11)45(61)34(8)69-53/h17-23,25,30,32-35,37-39,41-42,44-50,53-54,59,61-63H,14-16,24,26-29H2,1-13H3,(H,55,64)/b23-22+,31-25+/t32-,33+,34-,35+,37-,38-,39?,41-,42-,44+,45-,46+,47-,48-,49+,50+,53+,54+/m1/s1

Standard InChI Key:  GYTUURXBWRVTIX-WQJIWLIASA-N

Alternative Forms

  1. Parent:

    ALA4549457

    ---

Associated Targets(non-human)

Aliivibrio fischeri (131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1018.30Molecular Weight (Monoisotopic): 1017.6137AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Budragchaa T, Westermann B, Wessjohann LA..  (2019)  Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria.,  27  (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046]

Source